Active transcytosis and new opportunities for cancer nanomedicine

New evidence suggests that the mechanism of nanoparticle entry into solid tumours may be driven by an active process. This insight paves the way for approaches to enhance the efficiency of nanomedicine delivery by harnessing active transport mechanisms, and encourage researchers to rethink how tumours are treated.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Active and passive mechanisms for in vivo nanoparticle delivery.

References

  1. 1.

    Chan, W. C. W. Acc. Chem. Res. 50, 627–632 (2017).

    CAS  Article  Google Scholar 

  2. 2.

    Nakamura, H., Jun, F. & Maeda, H. Expert Opin. Drug Deliv. 12, 53–64 (2015).

    CAS  Article  Google Scholar 

  3. 3.

    Wilhelm, S. et al. Nat. Rev. Mater 1, 16014 (2016).

    CAS  Article  Google Scholar 

  4. 4.

    Shi, J., Kantoff, P., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).

    CAS  Article  Google Scholar 

  5. 5.

    Sindhwani, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-019-0566-2 (2020).

  6. 6.

    Hobbs, S. K. et al. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).

    CAS  Article  Google Scholar 

  7. 7.

    Schnitzer, J. E. Am. J. Physiol. Heart Circ. Physiol. 262, H246–H254 (1992).

    CAS  Article  Google Scholar 

  8. 8.

    Dvorak, H. F., Nagy, J. A., Dvorak, J. T. & Dvorak, A. M. Am. J. Pathol. 133, 95–109 (1988).

    CAS  Google Scholar 

  9. 9.

    Oh, P. et al. Nat. Med. 20, 1062–1068 (2014).

    CAS  Google Scholar 

  10. 10.

    Liu, Y. et al. Nano Lett. 19, 8010–8020 (2019).

    CAS  Article  Google Scholar 

  11. 11.

    Detampel, P. et al. PloS ONE 14, e0223339 (2019).

    CAS  Article  Google Scholar 

  12. 12.

    Ayloo, S. & Gu, C. Curr. Opinion Neurobiol. 57, 32–38 (2019).

    CAS  Article  Google Scholar 

  13. 13.

    Wiley, D. T., Webster, P., Gale, A. & Davis, M. E. Proc. Natl Acad. Sci. USA 110, 8662–8667 (2013).

    CAS  Article  Google Scholar 

  14. 14.

    Zhou, Q. et al. Nat. Nanotechnol. 14, 799–809 (2019).

    CAS  Article  Google Scholar 

  15. 15.

    Ruan, G., Agrawal, A., Marcus, A. I. & Nie, S. J. Am. Chem. Soc. 129, 14759–14766 (2007).

    CAS  Article  Google Scholar 

  16. 16.

    Ruoslahti, E. Adv. Drug Deliv. Rev. 110–111, 3–12 (2017).

    Article  Google Scholar 

  17. 17.

    Schmid, D. et al. Nat. Commun. 8, 1747 (2017).

    Article  Google Scholar 

  18. 18.

    Ledford, H. Nature 497, 544–544 (2013).

    CAS  Google Scholar 

  19. 19.

    Syn, N. L., Teng, M. W. L., Mok, T. S. K. & Soo, R. A. Lancet Oncol. 18, e731–e741 (2017).

    Article  Google Scholar 

  20. 20.

    Jiang, W. et al. Nat. Biomed. Eng. 1, 0029 (2017).

    CAS  Article  Google Scholar 

  21. 21.

    Reinhard, K. et al. Science 367, 446–453 (2020).

    CAS  Article  Google Scholar 

  22. 22.

    Sahin, U. et al. Nature 547, 222–226 (2017).

    CAS  Article  Google Scholar 

  23. 23.

    Yuan, H. et al. Nat. Nanotechnol. 12, 763–769 (2017).

    CAS  Article  Google Scholar 

  24. 24.

    Chen, Q. et al. Nat. Commun. 7, 13193 (2016).

    CAS  Article  Google Scholar 

  25. 25.

    Kulkarni, A. et al. Proc. Natl Acad. Sci. USA 113, E2104–E2113 (2016).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Shuming Nie.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pandit, S., Dutta, D. & Nie, S. Active transcytosis and new opportunities for cancer nanomedicine. Nat. Mater. 19, 478–480 (2020). https://doi.org/10.1038/s41563-020-0672-1

Download citation